MyFinsight
Home
Blog
About
Cash and cash
equivalents
$797,798K
(33.21%↑ Y/Y)
Prepaid expenses and
other current assets
$52,683K
(3.47%↑ Y/Y)
Accounts receivable
$697K
(-64.00%↓ Y/Y)
Total current assets
$851,178K
(30.60%↑ Y/Y)
Other assets
$961K
(-89.25%↓ Y/Y)
Property and equipment,
net
$351K
(-52.37%↓ Y/Y)
Total assets
$852,490K
(28.88%↑ Y/Y)
Total liabilities and
stockholders equity
$852,490K
(28.88%↑ Y/Y)
Total stockholders
equity
$735,388K
(20.84%↑ Y/Y)
Total liabilities
$117,102K
(121.36%↑ Y/Y)
Accumulated deficit
-$1,898,353K
(-39.57%↓ Y/Y)
Additional paid-in capital
$2,632,996K
(33.86%↑ Y/Y)
Total current
liabilities
$117,102K
(121.36%↑ Y/Y)
Accumulated other
comprehensive income
$725K
(-58.26%↓ Y/Y)
Common stock, par value
0.0001 per share,...
$20K
(25.00%↑ Y/Y)
Accrued expenses and
other current...
$106,964K
(137.40%↑ Y/Y)
Accounts payable
$10,138K
(29.26%↑ Y/Y)
Back
Back
Balance Sheet
IMVT_BIG-svg
Immunovant, Inc. (IMVT)
IMVT_BIG-svg
source: myfinsight.com
Immunovant, Inc. (IMVT)